Intuitive Surgical, Inc. $ISRG Stock Position Reduced by Towarzystwo Funduszy Inwestycyjnych PZU SA

Towarzystwo Funduszy Inwestycyjnych PZU SA cut its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 83.0% during the fourth quarter, HoldingsChannel.com reports. The firm owned 6,408 shares of the medical equipment provider’s stock after selling 31,189 shares during the period. Intuitive Surgical makes up about 0.9% of Towarzystwo Funduszy Inwestycyjnych PZU SA’s portfolio, making the stock its 18th largest holding. Towarzystwo Funduszy Inwestycyjnych PZU SA’s holdings in Intuitive Surgical were worth $3,629,000 as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. Newbridge Financial Services Group Inc. grew its position in Intuitive Surgical by 300.0% in the fourth quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 33 shares in the last quarter. Holos Integrated Wealth LLC bought a new stake in Intuitive Surgical in the fourth quarter worth approximately $25,000. Olistico Wealth LLC bought a new stake in shares of Intuitive Surgical during the 4th quarter worth $28,000. Laurel Wealth Advisors LLC bought a new stake in shares of Intuitive Surgical during the 4th quarter worth $31,000. Finally, Turning Point Benefit Group Inc. boosted its holdings in shares of Intuitive Surgical by 833.3% during the 4th quarter. Turning Point Benefit Group Inc. now owns 56 shares of the medical equipment provider’s stock worth $32,000 after buying an additional 50 shares during the period. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Price Performance

NASDAQ:ISRG opened at $411.06 on Monday. The stock has a market cap of $145.58 billion, a P/E ratio of 49.83, a PEG ratio of 3.28 and a beta of 1.46. Intuitive Surgical, Inc. has a one year low of $396.68 and a one year high of $603.88. The company has a fifty day moving average price of $442.88 and a 200 day moving average price of $495.68.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 EPS for the quarter, beating the consensus estimate of $2.08 by $0.42. The firm had revenue of $2.77 billion during the quarter, compared to analysts’ expectations of $2.62 billion. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. The business’s quarterly revenue was up 23.0% compared to the same quarter last year. During the same period in the prior year, the company earned $1.81 EPS. As a group, equities research analysts anticipate that Intuitive Surgical, Inc. will post 8.57 EPS for the current year.

More Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Analyst coverage remains broadly constructive, with brokerage sentiment still at a “Moderate Buy” and recent EPS estimate increases signaling confidence in Intuitive Surgical’s growth outlook.
• Positive Sentiment: Recent commentary highlights that the company’s scale, cost discipline, and adoption of the da Vinci 5 platform could help protect margins even if tariffs and input costs remain a concern.
• Neutral Sentiment: Investor attention has increased around ISRG, which can support trading activity, but this appears more like watchlist interest than a fresh business catalyst.
• Neutral Sentiment: BofA trimmed its price target slightly to $515 from $520, which still implies upside but signals a bit less optimism than before. Article: BofA adjusts price target on Intuitive Surgical to $515 from $520
• Neutral Sentiment: Two executives sold shares under pre-arranged 10b5-1 plans, including EVP Gary Loeb and EVP Mark Brosius. The sales were relatively small and routine, so they are unlikely to be a major fundamental concern.
• Negative Sentiment: One recent research note was notably bearish, with Deutsche Bank cutting its target to $366 and maintaining a sell rating, reinforcing concerns that valuation may still be too rich despite the company’s strong operating performance.
• Negative Sentiment: Seeking Alpha published a view calling Intuitive Surgical an “excellent business, unattractive stock,” reflecting ongoing investor caution around the valuation. Article: Intuitive Surgical: Excellent Business, Unattractive Stock

Insider Activity at Intuitive Surgical

In related news, SVP Iman Jeddi sold 5,625 shares of the company’s stock in a transaction on Monday, June 1st. The shares were sold at an average price of $420.55, for a total transaction of $2,365,593.75. Following the completion of the transaction, the senior vice president directly owned 6,463 shares in the company, valued at $2,718,014.65. This represents a 46.53% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of the company’s stock in a transaction on Wednesday, June 10th. The shares were sold at an average price of $424.14, for a total transaction of $169,656.00. Following the transaction, the executive vice president owned 5,720 shares of the company’s stock, valued at approximately $2,426,080.80. The trade was a 6.54% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 7,169 shares of company stock worth $3,059,135 in the last ninety days. 0.60% of the stock is currently owned by insiders.

Analyst Ratings Changes

Several research firms recently issued reports on ISRG. Zacks Research downgraded shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a report on Monday, March 30th. Jefferies Financial Group decreased their price objective on shares of Intuitive Surgical from $560.00 to $515.00 and set a “hold” rating for the company in a report on Wednesday, April 22nd. Piper Sandler reaffirmed an “overweight” rating and set a $580.00 price objective on shares of Intuitive Surgical in a report on Tuesday, June 2nd. Barclays set a $651.00 price objective on shares of Intuitive Surgical and gave the stock an “overweight” rating in a report on Thursday, April 23rd. Finally, HSBC decreased their price objective on shares of Intuitive Surgical from $653.00 to $604.00 and set a “buy” rating for the company in a report on Wednesday, April 22nd. Nineteen analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $571.28.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.